BMBL vs GRPN

BMBL's Advanced Deterministic Scorecard reveals severe financial distress, highlighted by a critically low Piotroski F-Score of 2/9, indicating weak fundamental health. Despite attractive valuation multiples like a Forward P/E of 3.81 and Price/Book of 0.59, the company is plagued by negative earnings, shrinking revenues, and deteriorating profitability, with a -19.82% profit margin and -10.00% YoY revenue growth. Persistent negative earnings surprises, collapsing EPS trends (-87.9% YoY), and substantial insider selling—over $113M in the last six months—further erode confidence. While strong operating margins (26.88%) and solid liquidity (Current Ratio: 3.55) offer limited support, they are insufficient to offset the broader deterioration in earnings quality and investor sentiment.

GRPN exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a negative Price-to-Book ratio of -11.35, indicating negative shareholder equity. While the company maintains a high gross margin (90.79%) and a low forward P/E (6.74), these are overshadowed by stagnant revenue growth (1.80%) and a net profit margin of -16.76%. Liquidity is tight with a current ratio of 0.97, and the technical trend is completely bearish. Despite optimistic analyst price targets, the fundamental health indicators suggest a high risk of insolvency or further devaluation.